𝔖 Bobbio Scriptorium

✦ LIBER ✦

Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab

✍ Scribed by Al-Mutairi, Nawaf; Nour, Tarek; Al-Rqobah, Duha

Book ID: 120210541
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 197 KB
Volume: 13
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712598.2013.783561

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 2-year comparative open label randomiz

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

✍ Anna Rita Giardina; Angelo Ferrante; Francesco Ciccia; Rosalia Impastato; Maria 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 239 KB

The efficacy and safety of infliximab in

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

✍ Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; So 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 430 KB

A prospective, randomized, open-label, b

A prospective, randomized, open-label, blinded endpoint, parallel group pilot study comparing the effects of quinapril and losartan on arterial stiffness in patients with mild to moderate hypertension (AC/DC)

✍ D.H.G Smith; J.M Neutel; M.A Weber 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB

I-COMBINE Study: Assessment of Efficacy

I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 666 KB

I-ADD Study: Assessment of Efficacy and

I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 592 KB